All Stories

  1. Future fertility of patients with zero oocytes yield in their first IVF cycle attempt

    Article • PLoS ONE, February 2021, PLOS

    Prof Raoul Orvieto

  2. Is Day-4 morula biopsy a feasible alternative for preimplantation genetic testing?

    Article • PLoS ONE, September 2020, PLOS

    Prof Raoul Orvieto

  3. Can we predict oocyte maturation prior to denudation for intracytoplasmic sperm injection?

    Article • Gynecological Endocrinology, August 2019, Taylor & Francis

    Prof Raoul Orvieto, Dr. Yuval Yung

  4. Do poor-responder patients undergoing IVF benefit from splitting and increasing the daily gonadotropin dose?

    Article • Gynecological Endocrinology, April 2019, Taylor & Francis

    Prof Raoul Orvieto

  5. Does double trigger (GnRH-agonist + hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study

    Article • Gynecological Endocrinology, February 2019, Taylor & Francis

    Prof Raoul Orvieto

  6. Preimplantation embryos sex ratios in couples with four or more children of same sex, what should be expected from a preimplantation genetic diagnosis cycle?

    Article • Gynecological Endocrinology, February 2019, Taylor & Francis

    Prof Raoul Orvieto

  7. Biosimilar FSH preparations- are they identical twins or just siblings?

    Article • Reproductive Biology and Endocrinology, June 2016, Springer Science + Business Media

    Prof Raoul Orvieto

  8. The prostaglandin transporter (PGT) as a potential mediator of ovulation

    Article • Science Translational Medicine, May 2016, American Association for the Advancement of Science

    Prof Raoul Orvieto

  9. In vitro fertilization outcomes following placement of Essure® micro-inserts in patients with hydrosalpinges who previously failed IVF treatment – a multicenter study

    Article • Journal of Minimally Invasive Gynecology, May 2016, Elsevier

    Prof Raoul Orvieto

  10. Transplantations of frozen thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria

    Article • Fertility and Sterility, May 2016, Elsevier

    Prof Raoul Orvieto

  11. Does BPA alter steroid hormone synthesis in human granulosa cellsin vitro?

    Article • Human Reproduction, April 2016, Oxford University Press (OUP)

    Prof Raoul Orvieto

  12. Natural cycle frozen-thawed embryo transfer—can we improve cycle outcome?

    Article • Journal of Assisted Reproduction and Genetics, March 2016, Springer Science + Business Media

    Prof Raoul Orvieto

  13. Reproductive Outcome Is Favorable After Laparoscopic Resection of Bladder Endometriosis

    Article • Journal of Minimally Invasive Gynecology, March 2016, Elsevier

    Prof Raoul Orvieto

  14. Should pre-implantation genetic screening be implemented to routine clinical practice?

    Article • Gynecological Endocrinology, February 2016, Taylor & Francis

    Prof Raoul Orvieto

  15. FMR6 may play a role in the pathogenesis of fragile X-associated premature ovarian insufficiency

    Article • Gynecological Endocrinology, December 2015, Taylor & Francis

    Prof Raoul Orvieto

  16. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation

    Article • Journal of Ovarian Research, November 2015, Springer Science + Business Media

    Prof Raoul Orvieto

  17. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield

    Article • Reproductive BioMedicine Online, October 2015, Elsevier

    Prof Raoul Orvieto

  18. The prostaglandin transporter (PGT): a novel indispensable mediator of ovulation

    Article • Fertility and Sterility, September 2015, Elsevier

    Prof Raoul Orvieto

  19. Characterization of the human ovulatory non-coding transcriptome reveals mirnas as new regulators of the ovulatory cascade

    Article • Fertility and Sterility, September 2015, Elsevier

    Prof Raoul Orvieto

  20. The capacity to induce generation of premeiotic and meiotic cells from biopsies without sperm from nonobstructive azoospermic and klinefelter syndrome patients were different under in vitro culture conditions

    Article • Fertility and Sterility, September 2015, Elsevier

    Prof Raoul Orvieto

  21. Triggering final follicular maturation- hCG, GnRH-agonist or both, when and to whom?

    Article • Journal of Ovarian Research, August 2015, Springer Science + Business Media

    Prof Raoul Orvieto

  22. Interleukin-2 Production by Cultured Human Granulosa Cells

    Article • American Journal of Reproductive Immunology, July 2015, Wiley

    Prof Raoul Orvieto

  23. Perinatal Outcome After Fetal Reduction From Twin to Singleton

    Article • Obstetrical & Gynecological Survey, July 2015, Wolters Kluwer Health

    Prof Raoul Orvieto

  24. To pill or not to pill in GnRH antagonist cycles: what should be the appropriate wash-out period?

    Article • Reproductive BioMedicine Online, May 2015, Elsevier

    Prof Raoul Orvieto

  25. Faculty of 1000 evaluation for Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized contro...

    Article • March 2015, Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  26. A novel approach to normal responder patient with repeated implantation failures – a case report

    Article • Gynecological Endocrinology, March 2015, Taylor & Francis

    Prof Raoul Orvieto

  27. Perinatal outcome after fetal reduction from twin to singleton: to reduce or not to reduce?

    Article • Fertility and Sterility, February 2015, Elsevier

    Prof Raoul Orvieto

  28. Comment on “The Role of Overweight and Obesity in In Vitro Fertilization Outcomes of Poor Ovarian Responders”

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Prof Raoul Orvieto

  29. Does bariatric surgery improve ovarian stimulation characteristics, oocyte yield, or embryo quality?

    Article • Journal of Ovarian Research, December 2014, Springer Science + Business Media

    Prof Raoul Orvieto

  30. Anti Müllerian Hormone (AMH) level and expression in mural and cumulus cells in relation to age

    Article • Journal of Ovarian Research, December 2014, Springer Science + Business Media

    Prof Raoul Orvieto

  31. Interleukin-2 and SOCS-1 proteins involvement in the pathophysiology of severe ovarian hyperstimulation syndrome-a preliminary proof of concept

    Article • Journal of Ovarian Research, November 2014, Springer Science + Business Media

    Prof Raoul Orvieto

  32. Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes

    Article • Gynecological Endocrinology, November 2014, Taylor & Francis

    Prof Raoul Orvieto

  33. Chromosomal aneuploidies and DNA fragmentation of human spermatozoa from patients exposed to perfluorinated compounds

    Article • Andrologia, November 2014, Wiley

    Professor Paola Piomboni, Prof Raoul Orvieto

  34. Ultrashort flare gonadotropin-releasing hormone (GnRH) agonist/GnRH antagonist protocol: a valuable tool in the armamentarium of ovulation induction for in vitro fertilization

    Article • Fertility and Sterility, November 2014, Elsevier

    Prof Raoul Orvieto

  35. GnRH agonist versus GnRH antagonist in ovarian stimulation: has the ongoing debate resolved?

    Article • Reproductive BioMedicine Online, November 2014, Elsevier

    Prof Raoul Orvieto

  36. The ‘immunologic theory’ of preeclampsia revisited: a lesson from donor oocyte gestations

    Article • American Journal of Obstetrics and Gynecology, October 2014, Elsevier

    Prof Raoul Orvieto

  37. Ovarian performance, IVF results, pregnancies and live births indicate; fertility preservation using ovarian tissue harvesting and transplantation of thawed ovarian strips is effective

    Article • Fertility and Sterility, September 2014, Elsevier

    Prof Raoul Orvieto

  38. IVF outcome in azoospermic cancer survivors

    Article • Fertility and Sterility, September 2014, Elsevier

    Prof Raoul Orvieto

  39. Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low rate of mature oocytes

    Article • Fertility and Sterility, September 2014, Elsevier

    Prof Raoul Orvieto

  40. Elevated Levels of FMR1 mRNA in Granulosa Cells Are Associated with Low Ovarian Reserve in FMR1 Premutation Carriers

    Article • PLoS ONE, August 2014, PLOS

    Prof Raoul Orvieto

  41. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies

    Article • Fertility and Sterility, August 2014, Elsevier

    Prof Raoul Orvieto

  42. Is severe OHSS associated with adverse pregnancy outcomes? Evidence from a case–control study

    Article • Reproductive BioMedicine Online, August 2014, Elsevier

    Prof Raoul Orvieto

  43. Reactive oxygen species in follicular fluid may serve as biochemical markers to determine ovarian aging and follicular metabolic age

    Article • Gynecological Endocrinology, July 2014, Taylor & Francis

    Prof Raoul Orvieto

  44. Is the modified natural in vitro fertilization cycle justified in patients with “genuine” poor response to controlled ovarian hyperstimulation?

    Article • Fertility and Sterility, June 2014, Elsevier

    Prof Raoul Orvieto

  45. Treating patients with “thin” endometrium – an ongoing challenge

    Article • Gynecological Endocrinology, April 2014, Taylor & Francis

    Prof Raoul Orvieto

  46. Misoprostol treatment for early pregnancy failure does not impair future fertility

    Article • Gynecological Endocrinology, January 2014, Taylor & Francis

    Prof Raoul Orvieto

  47. Pregnancy outcome in severe OHSS patients following ascitic/plerural fluid drainage

    Article • Journal of Ovarian Research, January 2014, Springer Science + Business Media

    Prof Raoul Orvieto

  48. 674: Is severe ovarian hyperstimulation syndrome associated with adverse pregnancy outcome? Evidence from a large case-control study

    Article • American Journal of Obstetrics and Gynecology, January 2014, Elsevier

    Prof Raoul Orvieto

  49. Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles-a preliminary report

    Article • Journal of Ovarian Research, January 2014, Springer Science + Business Media

    Prof Raoul Orvieto

  50. HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept

    Article • Journal of Ovarian Research, January 2014, Springer Science + Business Media

    Prof Raoul Orvieto

  51. Should zygote intrafallopian transfer be offered to all patients with unexplained repeated in-vitro fertilization cycle failures?

    Article • Journal of Ovarian Research, January 2014, Springer Science + Business Media

    Prof Raoul Orvieto

  52. Case Report: Delayed intra-abdominal bleeding following trans-vaginal ultrasonography guided oocyte retrieval for in vitro fertilization in patients at risk for thrombo-embolic events under anticoagulant therapy

    Article • F1000Research, October 2013, Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  53. orvieto

    Article • F1000Research, September 2013, Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  54. Alterations in thyroid function among the different polycystic ovary syndrome phenotypes

    Article • Gynecological Endocrinology, August 2013, Taylor & Francis

    Prof Raoul Orvieto

  55. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels

    Article • Gynecological Endocrinology, June 2013, Taylor & Francis

    Prof Raoul Orvieto

  56. Early pregnancy

    Article • Human Reproduction, June 2013, Oxford University Press (OUP)

    Mr Vikram Sinai Talaulikar, Prof Raoul Orvieto

  57. Male and female fertility preservation

    Article • Human Reproduction, June 2013, Oxford University Press (OUP)

    Prof Raoul Orvieto

  58. Effects of treatment of ectopic pregnancy with methotrexate or salpingectomy in the subsequent IVF cycle

    Article • Reproductive BioMedicine Online, May 2013, Elsevier

    Prof Raoul Orvieto

  59. Congenital malformations in infants conceived following assisted reproductive technology in comparison with spontaneously conceived infants

    Article • The Journal of Maternal-Fetal & Neonatal Medicine, March 2013, Taylor & Francis

    Prof Raoul Orvieto

  60. GnRH agonist versus GnRH antagonist in ovarian stimulation: an ongoing debate

    Article • Reproductive BioMedicine Online, January 2013, Elsevier

    Prof Raoul Orvieto

  61. Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma

    Article • Journal of Ovarian Research, January 2013, Springer Science + Business Media

    Prof Raoul Orvieto

  62. Timing of human chorionic gonadotropin trigger, in patients undergoing controlled ovarian hyperstimulation for IVF, using the GnRH antagonist protocol

    Article • Human Fertility, November 2012, Taylor & Francis

    Prof Raoul Orvieto

  63. The ultrashort flare GnRH-agonist/GnRH-antagonist protocol enables cycle programming and may overcome the “detrimental effect” of the oral contraceptive

    Article • Fertility and Sterility, September 2012, Elsevier

    Prof Raoul Orvieto

  64. Testicular biopsies from non-obstructive azoospermic patients expressed different pre-meiotic cell markers

    Article • Fertility and Sterility, September 2012, Elsevier

    Prof Raoul Orvieto

  65. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol

    Article • Gynecological Endocrinology, August 2012, Taylor & Francis

    Prof Raoul Orvieto

  66. Etiology of ovarian hyperstimulation syndrome

    Article • Fertility and Sterility, June 2012, Elsevier

    Prof Raoul Orvieto

  67. Elimination of ovarian hyperstimulation syndrome

    Article • Fertility and Sterility, June 2012, Elsevier

    Prof Raoul Orvieto

  68. Bleeding, severe pelvic infection, and ectopic pregnancy

    Article • June 2012, Taylor & Francis

    Prof Raoul Orvieto

  69. Intensive luteal-phase support with oestradiol and progesterone after GnRH-agonist triggering: does it help?

    Article • Reproductive BioMedicine Online, June 2012, Elsevier

    Prof Raoul Orvieto

  70. Faculty of 1000 evaluation for Contraindications to progestin-only oral contraceptive pills among reproductive-aged women.

    Article • March 2012, Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  71. The role of CPK isoenzymes in predicting extrauterine early pregnancy

    Article • Archives of Gynecology and Obstetrics, March 2012, Springer Science + Business Media

    Prof Raoul Orvieto

  72. Does day-3 LH/FSH ratio influencein vitrofertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue?

    Article • Gynecological Endocrinology, February 2012, Taylor & Francis

    Prof Raoul Orvieto

  73. Insight: Prolonged Vaginal Bleeding during Central Precocious Puberty Therapy with a Long-acting Gonadotropin-Releasing Hormone Agonist: A Proposed Mechanism and Management Plan

    Article • Journal of Pediatric and Adolescent Gynecology, December 2011, Elsevier

    Prof Raoul Orvieto

  74. Possible improvements in human ovarian grafting by various host and graft treatments

    Article • Human Reproduction, November 2011, Oxford University Press (OUP)

    Prof Raoul Orvieto, Dr Or Friedman

  75. Human sperm aneuploidy: FISH analysis in fertile and infertile men

    Article • Expert Review of Obstetrics & Gynecology, November 2011, Taylor & Francis

    Prof Raoul Orvieto

  76. The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen

    Article • Fertility and Sterility, June 2011, Elsevier

    Prof Raoul Orvieto

  77. Metformin improves semen characteristics of oligo-terato-asthenozoospermic men with metabolic syndrome

    Article • Fertility and Sterility, May 2011, Elsevier

    Prof Raoul Orvieto

  78. Does salpingectomy affect the ipsilateral ovarian response to gonadotropin during in vitro fertilization–embryo transfer cycles?

    Article • Fertility and Sterility, April 2011, Elsevier

    Prof Raoul Orvieto

  79. Improving posttransplantation survival of human ovarian tissue by treating the host and graft

    Article • Fertility and Sterility, March 2011, Elsevier

    Prof Raoul Orvieto

  80. The impact of environmental exposure to perfluorinated compounds on oocyte fertilization capacity

    Article • Journal of Assisted Reproduction and Genetics, February 2011, Springer Science + Business Media

    Prof Raoul Orvieto

  81. The role of 3-dimensional ultrasound for the diagnosis of congenital uterine anomalies

    Article • Open Journal of Obstetrics and Gynecology, January 2011, Scientific Research Publishing, Inc,

    Prof Raoul Orvieto

  82. POSTER VIEWING SESSION - MALE AND FEMALE FERTILITY PRESERVATION

    Article • Human Reproduction, January 2011, Oxford University Press (OUP)

    Prof Raoul Orvieto

  83. A combined approach to patients with repeated IVF failures

    Article • Fertility and Sterility, November 2010, Elsevier

    Prof Raoul Orvieto

  84. P24.18: Centralization and U turn of uterine arteries demonstrated by three dimensional power Doppler flow are new imaging signs for diagnosis of complete uterine inversion

    Article • Ultrasound in Obstetrics and Gynecology, October 2010, Wiley

    Prof Raoul Orvieto

  85. Human menopausal gonadotropin versus highly purified-hMG in controlled ovarian hyperstimulation forin-vitrofertilisation: does purity improve outcome?

    Article • Gynecological Endocrinology, May 2010, Taylor & Francis

    Prof Raoul Orvieto

  86. Infertility counseling for Orthodox Jewish couples

    Article • Fertility and Sterility, April 2010, Elsevier

    Prof Raoul Orvieto

  87. Administration of clomiphene citrate in patients with polycystic ovary syndrome, without inducing withdrawal bleeding, achieves comparable treatment characteristics and outcome

    Article • Fertility and Sterility, April 2010, Elsevier

    Prof Raoul Orvieto

  88. The association between follicular size on human chorionic gonadotropin day and pregnancy rate in clomiphene citrate treated polycystic ovary syndrome patients

    Article • Gynecological Endocrinology, March 2010, Taylor & Francis

    Prof Raoul Orvieto

  89. Cumulative clinical pregnancy rates after COH and IUI in subfertile couples

    Article • Gynecological Endocrinology, November 2009, Taylor & Francis

    Prof Raoul Orvieto

  90. Transplantation of frozen–thawed late-gestational-age human fetal ovaries into immunodeficient mice

    Article • Fertility and Sterility, August 2009, Elsevier

    Prof Raoul Orvieto

  91. Influence of smoking on outcome of COH and IUI in subfertile couples

    Article • Journal of Assisted Reproduction and Genetics, July 2009, Springer Science + Business Media

    Prof Raoul Orvieto

  92. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy

    Article • Fertility and Sterility, April 2009, Elsevier

    Prof Raoul Orvieto

  93. Follitropin-α (Gonal-F) versus follitropin-β (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?

    Article • Fertility and Sterility, April 2009, Elsevier

    Prof Raoul Orvieto

  94. Do stimulation characteristics of the first in vitro fertilization cycle predict pregnancy in women of 40 years old and over?

    Article • Fertility and Sterility, April 2009, Elsevier

    Prof Raoul Orvieto

  95. Is there a limit for the number of in vitro fertilization cycles for an individual patient?

    Article • Fertility and Sterility, April 2009, Elsevier

    Prof Raoul Orvieto

  96. Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality

    Article • Fertility and Sterility, April 2009, Elsevier

    Prof Raoul Orvieto

  97. What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?

    Article • Fertility and Sterility, April 2009, Elsevier

    Prof Raoul Orvieto

  98. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists

    Article • Fertility and Sterility, April 2009, Elsevier

    Prof Raoul Orvieto

  99. GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a priori

    Article • Fertility and Sterility, April 2009, Elsevier

    Prof Raoul Orvieto

  100. HMG improves IVF outcome in patients with high basal FSH/LH ratio: a preliminary study

    Article • Reproductive BioMedicine Online, January 2009, Elsevier

    Prof Raoul Orvieto

  101. Ovarian stimulation in polycystic ovary syndrome patients: the role of body mass index

    Article • Reproductive BioMedicine Online, January 2009, Elsevier

    Prof Raoul Orvieto

  102. Bleeding, severe pelvic infection and ectopic pregnancy

    Article • November 2008, Taylor & Francis

    Prof Raoul Orvieto

  103. The influence of body mass index on in vitro fertilization outcome

    Article • International Journal of Gynecology & Obstetrics, October 2008, Wiley

    Prof Raoul Orvieto

  104. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity

    Article • Fertility and Sterility, October 2008, Elsevier

    Prof Raoul Orvieto

  105. Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?

    Article • Fertility and Sterility, October 2008, Elsevier

    Prof Raoul Orvieto

  106. OP12.10: The role of 3-D ultrasound study of the endometrium in differentiating intrauterine versus extrauterine pregnancy

    Article • Ultrasound in Obstetrics and Gynecology, August 2008, Wiley

    Prof Raoul Orvieto

  107. The sperm chemoattractant secreted from human cumulus cells is progesterone

    Article • Human Reproduction, July 2008, Oxford University Press (OUP)

    Prof Raoul Orvieto

  108. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs

    Article • Fertility and Sterility, July 2008, Elsevier

    Prof Raoul Orvieto

  109. Controlled ovarian hyperstimulation: are we monitoring the appropriate sex-steroid hormones?

    Article • Fertility and Sterility, May 2008, Elsevier

    Prof Raoul Orvieto

  110. Reply: Appropriate methods to monitor controlled ovarian hyperstimulation?

    Article • Fertility and Sterility, April 2008, Elsevier

    Prof Raoul Orvieto

  111. Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?

    Article • Fertility and Sterility, March 2008, Elsevier

    Prof Raoul Orvieto

  112. GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome

    Article • Fertility and Sterility, February 2008, Elsevier

    Prof Raoul Orvieto

  113. Selection of patients before and after anticancer treatment for ovarian cryopreservation

    Article • Human Reproduction, January 2008, Oxford University Press (OUP)

    Prof Raoul Orvieto

  114. Comparison of embryo quality between intracytoplasmic sperm injection and in vitro fertilization in sibling oocytes

    Article • Journal of Assisted Reproduction and Genetics, January 2008, Springer Science + Business Media

    Prof Raoul Orvieto

  115. Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome

    Article • Human Reproduction, September 2007, Oxford University Press (OUP)

    Prof Raoul Orvieto

  116. OP15.06: The use of 3D ultrasound for diagnosis of unicornuate and didelphys uteri with twins gestation during first trimester of pregnancy

    Article • Ultrasound in Obstetrics and Gynecology, September 2007, Wiley

    Prof Raoul Orvieto

  117. Letter to the Editor

    Article • Journal of Andrology, May 2007, Wiley

    Prof Raoul Orvieto

  118. Low endometrial volume may predict early pregnancy loss in women undergoing in vitro fertilization

    Article • Journal of Assisted Reproduction and Genetics, March 2007, Springer Science + Business Media

    Prof Raoul Orvieto

  119. Use of three-dimensional ultrasound in evaluating the intrauterine position of a levonorgestrel-releasing intrauterine system

    Article • Reproductive BioMedicine Online, January 2007, Elsevier

    Prof Raoul Orvieto

  120. Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol

    Article • Gynecological Endocrinology, January 2007, Taylor & Francis

    Prof Raoul Orvieto

  121. A simplified approach to religious infertility

    Article • Fertility and Sterility, December 2006, Elsevier

    Prof Raoul Orvieto

  122. Soluble CD40 Ligand Levels during Controlled Ovarian Hyperstimulation – A Possible Culprit of Systemic Inflammation

    Article • American Journal of Reproductive Immunology, October 2006, Wiley

    Prof Raoul Orvieto

  123. Risk factors for failure to extend labor epidural analgesia to epidural anesthesia for Cesarean section

    Article • Acta Anaesthesiologica Scandinavica, September 2006, Wiley

    Prof Raoul Orvieto

  124. P19.03: 3D study of uterine and endometrial parameters in uteri with Mullerian anomalies versus normal uteri

    Article • Ultrasound in Obstetrics and Gynecology, August 2006, Wiley

    Prof Raoul Orvieto

  125. Risk factors for failure to extend labor epidural analgesia to epidural anesthesia for Cesarean section*

    Article • Acta Anaesthesiologica Scandinavica, August 2006, Wiley

    Prof Raoul Orvieto

  126. Müllerian anomalies, hearing loss, and connexin 26 mutations

    Article • Fertility and Sterility, June 2006, Elsevier

    Prof Raoul Orvieto

  127. Serum anti-müllerian hormone levels in women with secondary amenorrhea

    Article • Fertility and Sterility, May 2006, Elsevier

    Prof Raoul Orvieto

  128. Serum-Soluble CD40 Ligand in Normal Pregnancy and in Preeclampsia

    Article • Obstetrics and Gynecology, April 2006, Wolters Kluwer Health

    Prof Raoul Orvieto

  129. Does gravidity influence the success ofin vitrofertilization–embryo transfer cycles?

    Article • Gynecological Endocrinology, January 2006, Taylor & Francis

    Prof Raoul Orvieto

  130. Substituting HCG with GnRH agonist to trigger final follicular maturation – a retrospective comparison of three different ovarian stimulation protocols

    Article • Reproductive BioMedicine Online, January 2006, Elsevier

    Prof Raoul Orvieto

  131. Hysteroscopy combined with hysterosalpingo contrast sonography (HyCoSy): A new modality for comprehensive evaluation of the female pelvic organs

    Article • Gynecological Endocrinology, January 2006, Taylor & Francis

    Prof Raoul Orvieto

  132. Substituting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less systemic inflammation

    Article • Gynecological Endocrinology, January 2006, Taylor & Francis

    Prof Raoul Orvieto

  133. Use of various contraceptive methods and time of conception in a community-based population

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, November 2005, Elsevier

    Prof Raoul Orvieto

  134. Anti-Mullerian Hormone in Premenopausal Women and After Spontaneous or Surgically Induced Menopause

    Article • Journal of the Society for Gynecologic Investigation, October 2005, SAGE Publications

    Prof Raoul Orvieto

  135. Ovarian androgens but not estrogens correlate with the degree of systemic inflammation observed during controlled ovarian hyperstimulation

    Article • Gynecological Endocrinology, September 2005, Taylor & Francis

    Prof Raoul Orvieto

  136. C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle

    Article • Human Reproduction, June 2005, Oxford University Press (OUP)

    Prof Raoul Orvieto

  137. Reply: Can we eliminate severe ovarian hyperstimulation syndrome?

    Article • Human Reproduction, April 2005, Oxford University Press (OUP)

    Prof Raoul Orvieto

  138. Replies: Can we eliminate severe ovarian hyperstimulation syndrome. Comments 1 and 2

    Article • Human Reproduction, April 2005, Oxford University Press (OUP)

    Prof Raoul Orvieto

  139. The influence of urinary versus recombinant gonadotropin on serum P-selectin levelsin vivo

    Article • Gynecological Endocrinology, April 2005, Taylor & Francis

    Prof Raoul Orvieto

  140. Immediate ambulation after embryo transfer: A prospective study

    Article • Fertility and Sterility, March 2005, Elsevier

    Prof Raoul Orvieto

  141. Insulin autoantibodies in cord blood from neonates with and without a sibling with type 1 diabetes—prevalence and characterization

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, February 2005, Elsevier

    Prof Raoul Orvieto

  142. Chapter-19 Ovarian Hyperstimulation Syndrome

    Article • January 2005, Jaypee Brothers Medical Publishing

    Prof Raoul Orvieto

  143. Serum androgen levels in patients undergoing controlled ovarian hyperstimulation forin vitrofertilization cycles

    Article • Gynecological Endocrinology, January 2005, Taylor & Francis

    Prof Raoul Orvieto

  144. Controlled ovarian hyperstimulation: Does prolonged stimulation justify cancellation ofin vitrofertilization cycles?

    Article • Gynecological Endocrinology, January 2005, Taylor & Francis

    Prof Raoul Orvieto

  145. Does intravaginal probiotic supplementation increase the pregnancy rate in IVF–embryo transfer cycles?

    Article • Reproductive BioMedicine Online, January 2005, Elsevier

    Prof Raoul Orvieto

  146. Gestrinone in the treatment of uterine leiomyomata: Effects on uterine blood supply

    Article • Fertility and Sterility, December 2004, Elsevier

    Prof Raoul Orvieto

  147. Effect of urinary versus recombinant follicle-stimulating hormone on platelet function and other hemostatic variables in controlled ovarian hyperstimulation

    Article • Fertility and Sterility, December 2004, Elsevier

    Prof Raoul Orvieto

  148. Can we eliminate severe ovarian hyperstimulation syndrome?

    Article • Reviews in Gynaecological Practice, December 2004, Elsevier

    Prof Raoul Orvieto

  149. Can we eliminate severe ovarian hyperstimulation syndrome?

    Article • Human Reproduction, November 2004, Oxford University Press (OUP)

    Prof Raoul Orvieto

  150. Müllerian-inhibiting substance in women with polycystic ovary syndrome: Relationship with hormonal and metabolic characteristics

    Article • Fertility and Sterility, October 2004, Elsevier

    Prof Raoul Orvieto

  151. Controlled Ovarian Hyperstimulation—An Inflammatory State

    Article • Journal of the Society for Gynecologic Investigation, October 2004, SAGE Publications

    Prof Raoul Orvieto

  152. Significance of Increased Endometrial Thickness in Assisted Reproduction Technology Treatments

    Article • Journal of Assisted Reproduction and Genetics, August 2004, Springer Science + Business Media

    Prof Raoul Orvieto

  153. Serum P-selectin Level During Controlled Ovarian Hyperstimulation - a Preliminary Report

    Article • American Journal of Reproductive Immunology, August 2004, Wiley

    Prof Raoul Orvieto

  154. Use of color Doppler sonography during follicular aspiration in patients undergoing in vitro fertilization may reduce the risk of blood vessel injury

    Article • Fertility and Sterility, May 2004, Elsevier

    Prof Raoul Orvieto

  155. C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle

    Article • Human Reproduction, February 2004, Oxford University Press (OUP)

    Prof Raoul Orvieto

  156. Results ofin vitrofertilization cycles in women aged 43–45 years

    Article • Gynecological Endocrinology, January 2004, Taylor & Francis

    Prof Raoul Orvieto

  157. Effect of contaminated preprocessed semen on fertilization rate and embryo quality in assisted reproductive techniques

    Article • Gynecological Endocrinology, January 2004, Taylor & Francis

    Prof Raoul Orvieto

  158. Inclusion of standard and low-dose gonadotropin releasing hormone-analog (short protocol) in controlled ovarian hyperstimulation regimens in normogonadotropic patients aged 40-48 years who are undergoing in vitro fertilization

    Article • Gynecological Endocrinology, January 2004, Taylor & Francis

    Prof Raoul Orvieto

  159. Insulin autoantibodies in cord blood from neonates with and without a sibling with type 1 diabetes: prevalence and characteristics

    Article • American Journal of Obstetrics and Gynecology, December 2003, Elsevier

    Prof Raoul Orvieto

  160. Attitudes of Israeli gynecologists regarding candidate screening and personal responsibility in assisted reproductive technologies versus adoption in Israel

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, September 2003, Elsevier

    Prof Raoul Orvieto

  161. Interleukin-2 Production in Whole Blood Cell Cultures of Women Undergoing Controlled Ovarian Hyperstimulation for Assisted Reproduction Technology Cycles

    Article • American Journal of Reproductive Immunology, September 2003, Wiley

    Prof Raoul Orvieto

  162. Cobalamin (vitamin B12) metabolism during pregnancy

    Article • International Journal of Gynecology & Obstetrics, August 2003, Wiley

    Prof Raoul Orvieto

  163. Parameters affecting successful transplantation of frozen-thawed human fetal ovaries into immunodeficient mice

    Article • Fertility and Sterility, August 2003, Elsevier

    Prof Raoul Orvieto

  164. Prediction of ovarian hyperstimulation syndrome: Challenging the estradiol mythos

    Article • Human Reproduction, April 2003, Oxford University Press (OUP)

    Prof Raoul Orvieto

  165. Polycystic ovary syndrome: a simplified approach based on the evolving set of symptoms

    Article • Human Reproduction, April 2003, Oxford University Press (OUP)

    Prof Raoul Orvieto

  166. The ‘virtual’ cervical internal os: diagnosis during the first trimester of pregnancy

    Article • Ultrasound in Obstetrics and Gynecology, February 2003, Wiley

    Prof Raoul Orvieto

  167. Chapter-57 Endometrial Preparation for Patients Undergoing Frozen-Thawed Embryo Transfer Cycles

    Article • January 2003, Jaypee Brothers Medical Publishing

    Prof Raoul Orvieto

  168. Nonobstructive Dilatation of the Fetal Bowel in Twin Gestations

    Article • Fetal Diagnosis and Therapy, January 2003, Karger Publishers

    Prof Raoul Orvieto

  169. Comparison of leuprolide acetate and triptorelin in assisted reproductive technology cycles: a prospective, randomized study

    Article • Fertility and Sterility, December 2002, Elsevier

    Prof Raoul Orvieto

  170. Preliminary studies on apoptosis in human fetal ovaries

    Article • Fertility and Sterility, August 2002, Elsevier

    Prof Raoul Orvieto

  171. Echogenic Bowel in Intrauterine Growth Restriction Fetuses

    Article • Obstetrics and Gynecology, July 2002, Wolters Kluwer Health

    Prof Raoul Orvieto

  172. Munchausen syndrome in obstetrics and gynecology

    Article • Journal of Psychosomatic Obstetrics & Gynecology, January 2002, Taylor & Francis

    Prof Raoul Orvieto

  173. Plasma Levels of Vitamin E in Pregnant Women prior to the Development of Preeclampsia and Other Hypertensive Complications

    Article • Gynecologic and Obstetric Investigation, January 2002, Karger Publishers

    Prof Raoul Orvieto

  174. Influence of hormone replacement therapy on postmenopausal pelvic organs

    Article • Climacteric, June 2001, Taylor & Francis

    Prof Raoul Orvieto

  175. Brachial plexus injury and obstetrical risk factors

    Article • International Journal of Gynecology & Obstetrics, April 2001, Wiley

    Prof Raoul Orvieto

  176. Prediction of Pregnancy Outcome in Subgroups of Women With Renal Disease

    Article • Obstetrical & Gynecological Survey, March 2001, Wolters Kluwer Health

    Prof Raoul Orvieto

  177. Effect of Thrombophylaxis on Uterine and Fetal Circulation in Pregnant Women with a History of Pregnancy Complications

    Article • Thrombosis Research, February 2001, Elsevier

    Prof Raoul Orvieto

  178. Soluble L-selectin levels during controlled ovarian hyperstimulation

    Article • Gynecological Endocrinology, February 2001, Taylor & Francis

    Prof Raoul Orvieto

  179. Treatment of the twisted cystic ovary with normal blood flow by simple aspiration

    Article • Journal of Obstetrics and Gynaecology, January 2001, Taylor & Francis

    Prof Raoul Orvieto

  180. Influence of hormone replacement therapy on postmenopausal pelvic organs

    Article • Climacteric, January 2001, Taylor & Francis

    Prof Raoul Orvieto

  181. Soluble L-selectin levels during controlled ovarian hyperstimulation

    Article • Gynecological Endocrinology, January 2001, Taylor & Francis

    Prof Raoul Orvieto

  182. Double (consecutive) transfer of early embryos and blastocysts: aims and results

    Article • Fertility and Sterility, November 2000, Elsevier

    Prof Raoul Orvieto

  183. Controlled Ovarian Hyperstimulation - A State of Endothelial Activation1

    Article • American Journal of Reproductive Immunology, November 2000, Wiley

    Prof Raoul Orvieto

  184. F08Real-time intraoperative ultrasound guidance; the transrectal approach

    Article • Ultrasound in Obstetrics and Gynecology, October 2000, Wiley

    Prof Raoul Orvieto

  185. Polycystic ovary syndrome: a single gene mutation or an evolving set of symptoms

    Article • Current Opinion in Obstetrics & Gynecology, June 2000, Wolters Kluwer Health

    Prof Raoul Orvieto

  186. Effect of Metformin on Insulin-Like Growth Factor (IGF) I and IGF-Binding Protein I in Polycystic Ovary Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2000, Endocrine Society

    Prof Raoul Orvieto

  187. Pregnancy potential of embryos fromin vitrofertilization compared to intracytoplasmic sperm injection

    Article • Gynecological Endocrinology, January 2000, Taylor & Francis

    Prof Raoul Orvieto

  188. Natural-cyclein vitrofertilization in women aged over 44 years

    Article • Gynecological Endocrinology, January 2000, Taylor & Francis

    Prof Raoul Orvieto

  189. The rationale for requesting a second consecutive sperm ejaculate for assisted reproductive technology

    Article • Gynecological Endocrinology, January 2000, Taylor & Francis

    Prof Raoul Orvieto

  190. Gonadotropin stimulation following GnRH-a priming for poor responders inin vitrofertilization–embryo transfer programs

    Article • Gynecological Endocrinology, January 2000, Taylor & Francis

    Prof Raoul Orvieto

  191. Oral sildenafil may reverse secondary ejaculatory dysfunction during infertility treatment

    Article • Fertility and Sterility, December 1999, Elsevier

    Prof Raoul Orvieto

  192. Simplifying amniocentesis in paraplegic women—the wheelchair tilting manoeuvre

    Article • Prenatal Diagnosis, November 1999, Wiley

    Prof Raoul Orvieto

  193. Controlled Ovarian Hyperstimulation: A State of Neutrophil Activation

    Article • American Journal of Reproductive Immunology, November 1999, Wiley

    Prof Raoul Orvieto

  194. The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection

    Article • Fertility and Sterility, October 1999, Elsevier

    Prof Raoul Orvieto

  195. Endometrial polyps during menopause, characterization and significance

    Article • Acta Obstetricia Et Gynecologica Scandinavica, October 1999, Wiley

    Prof Raoul Orvieto

  196. Albumin in the prevention of severe OHSS: Reply

    Article • Human Reproduction, June 1999, Oxford University Press (OUP)

    Prof Raoul Orvieto

  197. Fetal middle-cerebral and umbilical artery flow assessments after glucose challenge test

    Article • International Journal of Gynecology & Obstetrics, June 1999, Wiley

    Prof Raoul Orvieto

  198. Evaluation of the upper uterine cervix by the location of the vesicocervical fold of the urinary bladder to rule out cervical shortening during pregnancy with and without premature contractions

    Article • Ultrasound in Obstetrics and Gynecology, June 1999, Wiley

    Prof Raoul Orvieto

  199. Assessment of fetal cardiovascular function: ultrasound study of the fetal circulatory compartments

    Article • Current Opinion in Obstetrics & Gynecology, April 1999, Wolters Kluwer Health

    Prof Raoul Orvieto

  200. Laparoscopic management of suspicious ovarian cysts in elderly, postmenopausal women

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, March 1999, Elsevier

    Prof Raoul Orvieto

  201. Pregnancy and multiple sclerosis: a 2-year experience

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, February 1999, Elsevier

    Prof Raoul Orvieto

  202. Does female age affect embryo morphology?

    Article • Gynecological Endocrinology, January 1999, Taylor & Francis

    Prof Raoul Orvieto

  203. Neonatal atrial flutter following fetal exposure to vibroacoustic stimulation

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, January 1999, Elsevier

    Prof Raoul Orvieto

  204. Pregnancy Outcome in Patients with Insulin Dependent Diabetes Mellitus and Diabetic Nephropathy Treated with ACE Inhibitors before Pregnancy

    Article • Journal of Pediatric Endocrinology and Metabolism, January 1999, De Gruyter

    Prof Raoul Orvieto

  205. Standardin vitrofertilization or intracytoplasmic sperm injection in advanced female age – what may be expected?

    Article • Gynecological Endocrinology, January 1999, Taylor & Francis

    Prof Raoul Orvieto

  206. Endometrial polyps during menopause, characterization and significance

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 1999, Wiley

    Prof Raoul Orvieto

  207. Role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome

    Article • Human Reproduction, December 1998, Oxford University Press (OUP)

    Prof Raoul Orvieto

  208. Pre-operative ultrasonographic evaluation of nongravid, enlarged uteri — correlation with bimanual examination

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, October 1998, Elsevier

    Prof Raoul Orvieto

  209. Single intrauterine fetal death (fetus papyraceus) due to uterine trauma in a twin pregnancy

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, October 1998, Elsevier

    Prof Raoul Orvieto

  210. Ovarian abscess after ovum retrieval for in-vitro fertilization

    Article • Human Reproduction, July 1998, Oxford University Press (OUP)

    Prof Raoul Orvieto

  211. Ovarian Hyperstimulation Syndrome: A New Insight Into an Old Enigma

    Article • Journal of the Society for Gynecologic Investigation, May 1998, SAGE Publications

    Prof Raoul Orvieto

  212. Abnormal Sonographic Endometrial Findings in Asymptomatic Postmenopausal Women

    Article • Menopause, May 1998, Wolters Kluwer Health

    Prof Raoul Orvieto

  213. Endometrial carcinoma in a post-menopausal woman with atrophic endometrium and intra-cavitary fluid: A case report

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, April 1998, Elsevier

    Prof Raoul Orvieto

  214. Twin gestation: Is there a correlation between the location of the gestational sacs at the beginning of pregnancy, and the order of delivery

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, April 1998, Elsevier

    Prof Raoul Orvieto

  215. Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist

    Article • Acta Obstetricia Et Gynecologica Scandinavica, March 1998, Wiley

    Prof Raoul Orvieto

  216. Asymptomatic postmenopausal intrauterine fluid accumulation; characterization and significance

    Article • Climacteric, January 1998, Taylor & Francis

    Prof Raoul Orvieto

  217. Flexible starting schedule for oral contraception: effect on the incidence of breakthrough bleeding and compliance

    Article • The European Journal of Contraception & Reproductive Health Care, January 1998, Taylor & Francis

    Prof Raoul Orvieto

  218. The impact of intrauterine contraceptive devices on cytological findings from routine Pap smear testing

    Article • The European Journal of Contraception & Reproductive Health Care, January 1998, Taylor & Francis

    Prof Raoul Orvieto

  219. Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 1998, Wiley

    Prof Raoul Orvieto

  220. A new concept of cotreatment with human growth hormone and menotropins in ovulation induction protocols

    Article • Medical Hypotheses, November 1997, Elsevier

    Prof Raoul Orvieto

  221. Morphology and clinical outcomes of embryos after in vitro fertilization are superior to those after intracytoplasmic sperm injection

    Article • Fertility and Sterility, October 1997, Elsevier

    Prof Raoul Orvieto

  222. Gestational diabetes and preterm labour: is glycaemic control a contributing factor?

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, June 1997, Elsevier

    Prof Raoul Orvieto

  223. CAUTION: PRENATAL CLUBFOOT CAN BE BOTH A TRANSIENT AND A LATE-ONSET PHENOMENON

    Article • Prenatal Diagnosis, May 1997, Wiley

    Prof Raoul Orvieto

  224. CAUTION: PRENATAL CLUBFOOT CAN BE BOTH A TRANSIENT AND A LATE‐ONSET PHENOMENON

    Article • Prenatal Diagnosis, May 1997, Wiley

    Prof Raoul Orvieto

  225. Torsion of a fallopian tube following Pomeroy tubal ligation: a rare case report and review of the literature

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, March 1997, Elsevier

    Prof Raoul Orvieto

  226. Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre- empting the rise in basal follicle stimulating hormone levels

    Article • Human Reproduction, February 1997, Oxford University Press (OUP)

    Prof Raoul Orvieto

  227. P-272 Fibrin sealant (FS) improves pregnancy rates in the elderly in-vitro fertilization (IVF) population, and maintains them within the more youthful range

    Article • Fertility and Sterility, January 1997, Elsevier

    Prof Raoul Orvieto

  228. P-15.

    Article • Menopause, January 1997, Wolters Kluwer Health

    Prof Raoul Orvieto

  229. P-16.

    Article • Menopause, January 1997, Wolters Kluwer Health

    Prof Raoul Orvieto

  230. Ovarian cysts and cyclic hormone replacement therapy: is there an association?

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 1997, Wiley

    Prof Raoul Orvieto

  231. The residual ovary syndrome: a 20-year experience

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, September 1996, Elsevier

    Prof Raoul Orvieto

  232. Uterine activity after betamethasone administration for the enhancement of fetal lung maturation

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, August 1996, Elsevier

    Prof Raoul Orvieto

  233. Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient

    Article • Human Reproduction, June 1996, Oxford University Press (OUP)

    Prof Raoul Orvieto

  234. The impact of woman's age and sperm parameters on fertilization rates in IVF cycles

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, June 1996, Elsevier

    Prof Raoul Orvieto

  235. Laparoscopic myomectomy today: The controversy of laparoscopic myomectomy

    Article • Human Reproduction, May 1996, Oxford University Press (OUP)

    Prof Raoul Orvieto

  236. Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome

    Article • Human Reproduction, April 1996, Oxford University Press (OUP)

    Prof Raoul Orvieto

  237. Prophylactic intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome

    Article • Human Reproduction, February 1996, Oxford University Press (OUP)

    Prof Raoul Orvieto

  238. A delayed starting schedule of oral contraception: The effect on the incidence of breakthrough bleeding and compliance in women

    Article • The European Journal of Contraception & Reproductive Health Care, January 1996, Taylor & Francis

    Prof Raoul Orvieto

  239. Etiology of ovarian hyperstimulation syndrome?

    Article • Fertility and Sterility, October 1995, Elsevier

    Prof Raoul Orvieto

  240. A severe case of ovarian hyperstimulation syndrome despite the prophylactic administration of intravenous albumin

    Article • Fertility and Sterility, October 1995, Elsevier

    Prof Raoul Orvieto

  241. The role of the immune system in severe ovarian hyperstimulation syndrome

    Article • Medical Hypotheses, September 1995, Elsevier

    Prof Raoul Orvieto

  242. Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient

    Article • Fertility and Sterility, September 1995, Elsevier

    Prof Raoul Orvieto

  243. The role of patient mobilization after embryo transfer in in vitro fertilization programs

    Article • American Journal of Obstetrics and Gynecology, June 1995, Elsevier

    Prof Raoul Orvieto

  244. Interleukin-2 and ovarian hyperstimulation syndrome: a pilot study

    Article • Human Reproduction, January 1995, Oxford University Press (OUP)

    Prof Raoul Orvieto

  245. Recurrent spontaneous ovarian hyperstimulation syndrome associated with polycystic ovary syndrome

    Article • Gynecological Endocrinology, January 1995, Taylor & Francis

    Prof Raoul Orvieto

  246. The role of cytokines in early detection of preeclampsia

    Article • Medical Hypotheses, November 1994, Elsevier

    Prof Raoul Orvieto

  247. Low-Back Pain of Pregnancy

    Article • Obstetrical & Gynecological Survey, November 1994, Wolters Kluwer Health

    Prof Raoul Orvieto

  248. The role of intrapartum vibroacoustic stimulation in the prediction of neonatal myasthenia gravis

    Article • Medical Hypotheses, February 1994, Elsevier

    Prof Raoul Orvieto

  249. Low-back pain of pregnancy

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 1994, Wiley

    Prof Raoul Orvieto

  250. The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program

    Article • Gynecological Endocrinology, January 1994, Taylor & Francis

    Prof Raoul Orvieto

  251. Cytokines - Involvement in reproduction

    Article • International Journal of Gynecology & Obstetrics, August 1993, Wiley

    Prof Raoul Orvieto

  252. The possible role of intravenous immunoglobulin in preventing pre-eclampsia

    Article • Medical Hypotheses, August 1993, Elsevier

    Prof Raoul Orvieto

  253. Cytokines—involvement in reproduction

    Article • Fertility and Sterility, December 1992, Elsevier

    Prof Raoul Orvieto

  254. Bone density, mineral content, and cortical index in patients with thalassemia major and the correlation to their bone fractures, blood transfusions, and treatment with desferrioxamine

    Article • Calcified Tissue International, May 1992, Springer Science + Business Media

    Prof Raoul Orvieto

  255. Intravenous immunoglobulin treatment for recurrent abortions caused by antiphospholipid antibodies

    Article • Fertility and Sterility, December 1991, Elsevier

    Prof Raoul Orvieto

  256. Intravenous immunoglobulin treatment of recurrent pregnancy loss and antiphospholipid antibodies

    Article • American Journal of Obstetrics and Gynecology, June 1991, Elsevier

    Prof Raoul Orvieto

  257. Effect of Smoking on Concentration, Motility and Zona-Free Hamster Test on Human Sperm

    Article • Archives of Andrology, January 1991, Taylor & Francis

    Prof Raoul Orvieto

  258. Faculty of 1000 evaluation for Postmenopausal skin and estrogen.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  259. Faculty of 1000 evaluation for Gonadotrophins for idiopathic male factor subfertility.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  260. Faculty of 1000 evaluation for In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  261. Faculty of 1000 evaluation for Cumulative birth rates with linked assisted reproductive technology cycles.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  262. Faculty of 1000 evaluation for Variability of Semen Parameters Over Time in Placebo-Treated Men.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  263. Faculty of 1000 evaluation for Intra-uterine insemination for unexplained subfertility.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  264. Faculty of 1000 evaluation for Klinefelter syndrome: an argument for early aggressive hormonal and fertility management.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  265. Faculty of 1000 evaluation for Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  266. Faculty of 1000 evaluation for Progesterone vaginal ring versus vaginal gel for luteal support with in vitro fertilization: a randomized comparative study.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  267. Faculty of 1000 evaluation for Ovarian responsiveness in women receiving fertility treatment after methotrexate for ectopic pregnancy: a systematic review and meta-analysis.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  268. Faculty of 1000 evaluation for GnRH agonist and GnRH antagonist protocols: comparison of outcomes among good-prognosis patients using national surveillance data V.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  269. Faculty of 1000 evaluation for Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  270. Faculty of 1000 evaluation for Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  271. Faculty of 1000 evaluation for Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  272. Faculty of 1000 evaluation for In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  273. Faculty of 1000 evaluation for Prevention of ovarian hyperstimulation syndrome in GnRH agonist IVF cycles in moderate risk patients: randomized study comparing hydroxyethyl starch versus cabergoline and hydroxyethyl starch.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  274. Faculty of 1000 evaluation for A randomized clinical trial to evaluate the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) in embryo culture medium for in vitro fertilization.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  275. Faculty of 1000 evaluation for Does intracytoplasmic morphologically selected sperm injection improve embryo development? A randomized sibling-oocyte study.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  276. Faculty of 1000 evaluation for In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  277. Faculty of 1000 evaluation for Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a randomized, controlled trial.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  278. Faculty of 1000 evaluation for The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  279. Faculty of 1000 evaluation for Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  280. Faculty of 1000 evaluation for Calcium infusion for the prevention of ovarian hyperstimulation syndrome: a double-blind randomized controlled trial.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  281. Faculty of 1000 evaluation for Effect of oxygen concentration on human embryo development evaluated by time-lapse monitoring.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  282. Faculty of 1000 evaluation for Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  283. Faculty of 1000 evaluation for GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  284. Faculty of 1000 evaluation for Low dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  285. Faculty of 1000 evaluation for Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrel.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  286. Faculty of 1000 evaluation for Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  287. Faculty of 1000 evaluation for Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  288. Faculty of 1000 evaluation for The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  289. Faculty of 1000 evaluation for High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model for clinical practice.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  290. Faculty of 1000 evaluation for No evidence that assisted reproduction increases the risk of thrombosis: a Danish National cohort study.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  291. Faculty of 1000 evaluation for The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  292. Faculty of 1000 evaluation for The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: A prospective randomized controlled study.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  293. Faculty of 1000 evaluation for A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  294. Faculty of 1000 evaluation for Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  295. Faculty of 1000 evaluation for A randomized controlled, non-inferiority trial of modified natural versus artificial cycle for cryo-thawed embryo transfer.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  296. Faculty of 1000 evaluation for A randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating factor in in vitro fertilization cycles: impact on endometrial thickness and clinical pregnancy rates.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  297. Faculty of 1000 evaluation for A large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagoni...

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  298. Faculty of 1000 evaluation for Use of hyaluronan in the selection of sperm for intracytoplasmic sperm injection (ICSI): significant improvement in clinical outcomes--multicenter, double-blinded and randomized controlled trial.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  299. Faculty of 1000 evaluation for Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  300. Faculty of 1000 evaluation for Morphologic abnormalities in 2-year-old children born after in vitro fertilization/intracytoplasmic sperm injection with preimplantation genetic screening: follow-up of a randomized controlled trial.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  301. Faculty of 1000 evaluation for Gonadotropin-Releasing Hormone Agonist for the Prevention of Chemotherapy-Induced Ovarian Failure in Patients With Lymphoma: 1-Year Follow-Up of a Prospective Randomized Trial.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto

  302. Faculty of 1000 evaluation for Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis.

    Article • Faculty of 1000, Ltd.

    Prof Raoul Orvieto